Erfan Nur

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Topics

Sickle Cell Disease

Mild Traumatic Brain Injury

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabeth Dovern, Mesire Aydin, Mette D Hazenberg, Man Wai Tang, Elisabeth M Suijk, Gerianne M Hoogendoorn, Charlotte F J Van Tuijn, Jean-Louis Kerkhoffs, Caroline E Rutten, Sacha S Zeerleder, Josu de la Fuente, Bart J Biemond, Erfan Nur
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study. American journal of hematology 99 (8) (2024)
Elisabeth Dovern, Mesire Aydin, Michael Rutledge DeBaun, Komeil Alizade, Bart J Biemond, Erfan Nur
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis. American journal of hematology 99 (6) (2024)
Elisabeth Dovern, Mesire Aydin, Mette D Hazenberg, Man Wai Tang, Elisabeth M Suijk, Gerianne M Hoogendoorn, Charlotte F J Van Tuijn, Jean-Louis Kerkhoffs, Caroline E Rutten, Sacha S Zeerleder, Josu de la Fuente, Bart J Biemond, Erfan Nur
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study. American journal of hematology 99 (8) (2024)
Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina Wilkerson, Ali D Alahmari, Adriana Seber, Carmem Maria Sales Bonfim, Belinda Pinto Simões, Mohsen Alzahrani, Michael J Eckrich, Biljana Horn, Rabi Hanna, Nathalie Dhedin, Hemalatha G Rangarajan, Roseane Vasconcelos Gouveia, Fahad Almohareb, Mahmoud Aljurf, Mohammed F Essa, Bader Alahmari, Katie S Gatwood, James A Connelly, Elisabeth Dovern, Mark Rodeghier, Michael Rutledge DeBaun
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease. Blood (2024)
Elisabeth Dovern, Mesire Aydin, Michael Rutledge DeBaun, Komeil Alizade, Bart J Biemond, Erfan Nur
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis. American journal of hematology 99 (6) (2024)
Lydian A de Ligt, Aafke E Gaartman, Bart J Biemond, Karin Fijnvandraat, Robin van Bruggen, Erfan Nur
Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target. American journal of hematology 99 (6) (2024)
Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina L Wilkerson, Ali D Alahmari, Adriana Seber, Carmem Maria Sales Bonfim, Belinda Pinto Simões, Mohsen Al Zahrani, Michael J Eckrich, Biljana Horn, Rabi Hanna, Nathalie Dhedin, Hemalatha G Rangarajan, Roseane Vasconcelos Gouveia, Fahad Almohareb, Mahmoud Aljurf, Mohammed F Essa, Bader Alahmari, Katie S Gatwood, James A Connelly, Elisabeth Dovern, Mark Rodeghier, Michael Rutledge DeBaun
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease. Blood 143 (25) (2024)
Flores Gerrit Weverling, Mieke Roeven, Clara Nijssen, Annoek E C Broers, Elisabeth Dovern, Anna van Rhenen, Geerte van Sluis, Carin L E Hazenberg, Peter van Balen, Maria T Kuipers, Karen M K de Vooght, Linde M Morsink, Jürgen H E Kuball, Erfan Nur, Moniek A de Witte
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood advances 8 (7) (2024)
Flores Gerrit Weverling, Mieke W H Roeven, Klaartje Kasper Nijssen, Annoek E C Broers, Elisabeth Dovern, Anna van Rhenen, Geerte van Sluis, Carin Hazenberg, Peter van Balen, Maria T Kuipers, Karen M K de Vooght, Linde M Morsink, Jürgen H E Kuball, Erfan Nur, Moniek Dewitte
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood advances (2024)
Lydian A de Ligt, Aafke E Gaartman, Bart J Biemond, Karin Fijnvandraat, Robin van Bruggen, Erfan Nur
Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target. American journal of hematology (2024)
Flores Gerrit Weverling, Mieke Roeven, Clara Nijssen, Annoek E C Broers, Elisabeth Dovern, Anna van Rhenen, Geerte van Sluis, Carin L E Hazenberg, Peter van Balen, Maria T Kuipers, Karen M K de Vooght, Linde M Morsink, Jürgen H E Kuball, Erfan Nur, Moniek A de Witte
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood advances 8 (7) (2024)
Alexa M G A Laheij, Linda M Dillen, Erfan Nur, Judith E Raber-Durlacher
Self-perceived oral health in hemato-oncological patients and the relation to quality of life. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (10) (2024)
Lydian A de Ligt, Aafke E Gaartman, Bart J Biemond, Karin Fijnvandraat, Robin van Bruggen, Erfan Nur
Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target. American journal of hematology 99 (6) (2024)
Elisabeth Dovern, Mesire Aydin, Mette D Hazenberg, Man Wai Tang, Elisabeth M Suijk, Gerianne M Hoogendoorn, Charlotte F J Van Tuijn, Jean-Louis Kerkhoffs, Caroline E Rutten, Sacha S Zeerleder, Josu de la Fuente, Bart J Biemond, Erfan Nur
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study. American journal of hematology 99 (8) (2024)
Lydian A de Ligt, Aafke E Gaartman, Bart J Biemond, Karin Fijnvandraat, Robin van Bruggen, Erfan Nur
Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target. American journal of hematology 99 (6) (2024)
Elisabeth Dovern, Mesire Aydin, Michael Rutledge DeBaun, Komeil Alizade, Bart J Biemond, Erfan Nur
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis. American journal of hematology 99 (6) (2024)
Flores Gerrit Weverling, Mieke Roeven, Clara Nijssen, Annoek E C Broers, Elisabeth Dovern, Anna van Rhenen, Geerte van Sluis, Carin L E Hazenberg, Peter van Balen, Maria T Kuipers, Karen M K de Vooght, Linde M Morsink, Jürgen H E Kuball, Erfan Nur, Moniek A de Witte
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood advances 8 (7) (2024)
Elisabeth Dovern, Mesire Aydin, Michael Rutledge DeBaun, Komeil Alizade, Bart J Biemond, Erfan Nur
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis. American journal of hematology (2024)
Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina Wilkerson, Ali D Alahmari, Adriana Seber, Carmem Maria Sales Bonfim, Belinda Pinto Simões, Mohsen Alzahrani, Michael J Eckrich, Biljana Horn, Rabi Hanna, Nathalie Dhedin, Hemalatha G Rangarajan, Roseane Vasconcelos Gouveia, Fahad Almohareb, Mahmoud Aljurf, Mohammed F Essa, Bader Alahmari, Katie S Gatwood, James A Connelly, Elisabeth Dovern, Mark Rodeghier, Michael Rutledge DeBaun
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease. Blood (2024)
Elisabeth Dovern, Mesire Aydin, Mette D Hazenberg, Man Wai Tang, Elisabeth M Suijk, Gerianne M Hoogendoorn, Charlotte F J Van Tuijn, Jean-Louis Kerkhoffs, Caroline E Rutten, Sacha S Zeerleder, Josu de la Fuente, Bart J Biemond, Erfan Nur
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study. American journal of hematology (2024)
Myrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs, Anita W Rijneveld, Marjon H Cnossen, Erfan Nur, Bart J Biemond, Marije Bartels, Judith J M Jans, W W van Solinge, Roger E G Schutgens, Richard van Wijk, Eduard J van Beers
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study. Blood advances (2023)
Mesire Aydin, David C de Leeuw, Caroline E Rutten, Otto J Visser, Man Wai Tang, Cinthy van Roessel, Jeroen J W Janssen, Bart J Biemond, Arjan A van de Loosdrecht, Mette D Hazenberg, Ellen Meijer, Erfan Nur
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning. British journal of haematology (2023)
Eline Houben, Pieter F de Groot, Yosta Vegting, Josephine M I M I Vos, Erfan Nur, Marc L Hilhorst, A E Liesbeth Hak, Arjan J Kwakernaak
Not Everything Is as It Seems: A Case Series and Overview of Diseases Mimicking Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Journal of clinical medicine 12 (19) (2023)
Rajani Priya Brandsen, Roselie M H Diederen, Siham Bakhlakh, Erfan Nur, Reinier O Schlingemann, Bart J Biemond
Natural history and rate of progression of retinopathy in adult sickle cell disease patients: an 11-year follow-up study. Blood advances (2023)
Minke A E Rab, Celeste K Kanne, Camille Boisson, Jennifer Bos, Brigitte A van Oirschot, Maite E Houwing, Céline Renoux, Marije Bartels, Anita W Rijneveld, Erfan Nur, Marjon H Cnossen, Philippe Joly, Elie Nader, Romain Fort, Philippe Connes, Richard van Wijk, Vivien A Sheehan, Eduard J van Beers
Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease. Blood advances (2023)
Charlotte C M Schaap, Floor C J I Heubel-Moenen, Erfan Nur, Marije Bartels, Olivier W H van der Heijden, Emiel de Jonge, Frank W M B Preijers, Nicole M A Blijlevens, Saskia M C Langemeijer, null null
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes. European journal of haematology (2023)
Aafke E Gaartman, Charlotte F J van Tuijn, Erfan Nur, Liffert Vogt, Bart J Biemond
The association between renal function decline and disease severity in sickle cell disease. American journal of hematology (2023)
Aafke E Gaartman, Charlotte F J van Tuijn, Erfan Nur, Liffert Vogt, Bart J Biemond
The association between renal function decline and disease severity in sickle cell disease. American journal of hematology (2023)
Aafke E Gaartman, Anniek Strijdhorst, Nick Van Es, Man Wai Tang, Jarom Heijmans, Bart J Biemond, Erfan Nur, null null
Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait. British journal of haematology 198 (3) (2022)
Myrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs, Anita W Rijneveld, Marjon H Cnossen, Erfan Nur, Bart J Biemond, Marije Bartels, Judith J M Jans, Wouter W van Solinge, Roger E G Schutgens, Richard van Wijk, Eduard J van Beers
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study. American journal of hematology 97 (7) (2022)
Annelies J van Vuren, Jean-Louis H Kerkhoffs, Saskia E M Schols, Anita Rijneveld, Erfan Nur, Dore Peereboom, Yves Gandon, Paco M J Welsing, Richard van Wijk, Roger E G Schutgens, Wouter W van Solinge, Joannes Marx, Tim Leiner, Bart J Biemond, Eduard J van Beers
Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial. American journal of hematology 97 (7) (2022)
Kadère Konté, Erfan Nur, Man Wai Tang, Jarom Heijmans, Charlotte F J van Tuijn, Bart J Biemond
Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study. International journal of laboratory hematology (2021)
Erfan Nur, Aafke E Gaartman, Charlotte F J van Tuijn, Man Wai Tang, Bart J Biemond
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19). American journal of hematology 95 (6) (2020)